Insulin resistance and fuel homeostasis: The role of AMP-activated protein kinase

Acta Physiologica

Volumn 196, Issue 1, 2009, Pages 129-145

  Hegarty, B D ^a   Turner, N ^a   Cooney, G J ^a   Kraegen, E W ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

AMPK; Energy homeostasis; Insulin resistance; Lipid accumulation; Liver; Muscle

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADIPOCYTOKINE; ADIPONECTIN; BERBERINE; ENZYME ACTIVATOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; POLYPHENOL DERIVATIVE; RESVERATROL; THIENOPYRIDONE DERIVATIVE; TRITERPENOID; UNCLASSIFIED DRUG;

CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME STRUCTURE; EXERCISE; FATTY ACID OXIDATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; INSULIN RESISTANCE; LIPID LIVER LEVEL; LIPID METABOLISM; LIPOGENESIS; LIVER; METABOLIC SYNDROME X; MOMORDICA CHARANTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADIPOKINES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DIABETES MELLITUS, TYPE 2; EXERCISE; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; METABOLIC SYNDROME X; MUSCLE, SKELETAL; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 63849125267     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2009.01968.x     Document Type: Conference Paper

References (163)

1. Antuna-Puente, B., Feve, B., Fellahi, S. Bastard, J.P. 2008. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 34, 2 11.
2. Assifi, M.M., Suchankova, G., Constant, S., Prentki, M., Saha, A.K. Ruderman, N.B. 2005. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. Am J Physiol Endocrinol Metab 289, E794 E800.
3. Bandyopadhyay, G.K., Yu, J.G., Ofrecio, J. Olefsky, J.M. 2006. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55, 2277 2285.
4. Banerjee, R.R., Rangwala, S.M., Shapiro, J.S., Rich, A.S., Rhoades, B., Qi, Y., Wang, J., Rajala, M.W., Pocai, A., Scherer, P.E., Steppan, C.M., Ahima, R.S., Obici, S., Rossetti, L. Lazar, M.A. 2004. Regulation of fasted blood glucose by resistin. Science 303, 1195 1198.
5. Barthel, A., Schmoll, D., Krüger, K.D., Roth, R.A. Joost, H.G. 2002. Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 143, 3183 3186.
6. Baur, J., Pearson, K., Price, N., Jamieson, H., Lerin, C., Kalra, A., Prabhu, V., Allard, J., Lopez-Lluch, G., Lewis, K. et al. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337 342.
7. Bergeron, R., Ren, J.M., Cadman, K.S., Moore, I.K., Perret, P., Pypaert, M., Young, L.H., Semenkovich, C.F. Shulman, G.I. 2001. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab 281, E1340 E1346.
8. Bjørbaek, C. Kahn, B.B. 2004. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59, 305 331.
9. Bjursell, M., Ahnmark, A., Bohlooly-Y, M., William-Olsson, L., Rhedin, M., Peng, X., Ploj, K., Gerdin, A., Arnerup, G., Elmgren, A., Berg, A., Oscarsson, J. Linden, D. 2007. Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56, 583 593.
10. Boesch, C., Slotboom, J., Hoppeler, H. Kreis, R. 1997. In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 37, 484 493.
11. Bonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M., Morio, B., Vidal, H. Rieusset, J. 2008. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118, 789 800.
12. Brabant, G., Müller, G., Horn, R., Anderwald, C., Roden, M. Nave, H. 2005. Hepatic leptin signaling in obesity. FASEB J 19, 1048 1050.
13. Brown, M.S. Goldstein, J.L. 2008. Selective versus total insulin resistance: a pathogenic paradox. Cell Metabolism 7, 95 96.
14. Bruce, C.R., Mertz, V.A., Heigenhauser, G.J. Dyck, D.J. 2005. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 54, 3154 3160.
15. Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhäusl, W. Fürnsinn, C. 2004. Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53, 1052 1059.
16. Buhl, E.S., Jessen, N., Pold, R., Ledet, T., Flyvbjerg, A., Pedersen, S.B., Pedersen, O., Schmitz, O. Lund, S. 2002. Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51, 2199 2206.
17. Carling, D., Zammit, V.A. Hardie, D.G. 1987. A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett 223, 217 222.
18. Carling, D., Sanders, M. Woods, A. 2008. The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond) 32 (Suppl. 4 S55 S59.
19. Chavez, J.A., Roach, W.G., Keller, S.R., Lane, W.S. Lienhard, G.E. 2008. Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation. J Biol Chem 283, 9187 9195.
20. Chen, M.B., McAinch, A.J., Macaulay, S.L., Castelli, L.A., O'brien, P.E., Dixon, J.B., Cameron-Smith, D., Kemp, B.E. Steinberg, G.R. 2005. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90, 3665 3672.
21. Chen, S., Murphy, J., Toth, R., Campbell, D.G., Morrice, N. Mackintosh, C. 2008. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J 409, 449 459.
22. Cheng, Z., Pang, T., Gu, M., Gao, A.H., Xie, C.M., Li, J.Y., Nan, F.J. Li, J. 2006. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim Biophys Acta 1760, 1682 1689.
23. Cleasby, M.E., Dzamko, N., Hegarty, B.D., Cooney, G.J., Kraegen, E.W. Ye, J.M. 2004. Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes 53, 3258 3266.
24. Cool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G., Iyengar, R. et al. 2006. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metabolism 3, 403 416.
25. Costford, S., Kavaslar, N., Ahituv, N., Chaudhry, S., Schackwitz, W., Dent, R., Pennacchio, L., Mcpherson, R. Harper, M. 2007. Gain-of-function R225W mutation in human AMPKgamma3 causing increased glycogen and decreased triglyceride in skeletal muscle. PLoS ONE 2, e903.
26. Cuthbertson, D.J., Babraj, J.A., Mustard, K.J., Towler, M.C., Green, K.A., Wackerhage, H., Leese, G.P., Baar, K., Thomason-Hughes, M., Sutherland, C., Hardie, D. Rennie, M.J. 2007. 5-aminoimidazole-4-carboxamide 1-beta-d-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men. Diabetes 56, 2078 2084.
27. Daval, M., Foufelle, F. Ferré, P. 2006. Functions of AMP-activated protein kinase in adipose tissue. J Physiol (Lond) 574, 55 62.
28. DeFronzo, R.A., Jacot, E., Jequier, E., Maeder, E., Wahren, J. Felber, J.P. 1981. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30, 1000 1007.
29. Eckel, R., Grundy, S. Zimmet, P. 2005. The metabolic syndrome. Lancet 365, 1415 1428.
30. Ferré, P., Azzout-Marniche, D. Foufelle, F. 2003. AMP-activated protein kinase and hepatic genes involved in glucose metabolism. Biochem Soc Trans 31, 220 223.
31. Fisher, J.S., Gao, J., Han, D.H., Holloszy, J.O. Nolte, L.A. 2002. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab 282, E18 E23.
32. Foretz, M., Carling, D., Guichard, C., Ferré, P. Foufelle, F. 1998. AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. J Biol Chem 273, 14767 14771.
33. Fryer, L.G., Parbu-Patel, A. Carling, D. 2002. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277, 25226 25232.
34. Fujii, N., Hayashi, T., Hirshman, M.F., Smith, J.T., Habinowski, S.A., Kaijser, L., Mu, J., Ljungqvist, O., Birnbaum, M., Witters, L.A., Thorell, A. Goodyear, L.J. 2000. Exercise induces isoform-specific increase in 5′AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 273, 1150 1155.
35. Fujii, N., Ho, R.C., Manabe, Y., Jessen, N., Toyoda, T., Holland, W.L., Summers, S.A., Hirshman, M.F. Goodyear, L.J. 2008. Ablation of AMP-activated protein kinase [alpha]2 activity exacerbates insulin resistance induced by high-fat feeding of mice. Diabetes 57, 2958 2966.
36. Gan, S.K., Samaras, K., Thompson, C.H., Kraegen, E.W., Carr, A., Cooper, D.A. Chisholm, D.J. 2002. Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes 51, 3163 3169.
37. Greco, A.V., Mingrone, G., Giancaterini, A., Manco, M., Morroni, M., Cinti, S., Granzotto, M., Vettor, R., Camastra, S. Ferrannini, E. 2002. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51, 144 151.
38. Guigas, B., Sakamato, K., Taleux, N., Reyna, S.M., Musi, N., Viollet, B. Hue, L. 2009. Beyond AICA riboside: In search of new specific AMP-activated protein kinase activators. IUBMB Life 61, 18 26.
39. Hardie, D. 2007. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 47, 185 210.
40. Hardie, D.G. 2008. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 32 (Suppl. 4 S7 S12.
41. Hawley, S.A., Pan, D.A., Mustard, K.J., Ross, L., Bain, J., Edelman, A.M., Frenguelli, B.G. Hardie, D. 2005. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metabolism 2, 9 19.
42. Hayashi, T., Hirshman, M.F., Kurth, E.J., Winder, W.W. Goodyear, L.J. 1998. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47, 1369 1373.
43. Hegarty, B.D., Cooney, G.J., Kraegen, E.W. Furler, S.M. 2002. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51, 1477 1484.
44. Hegarty, B.D., Furler, S.M., Ye, J.M., Cooney, G.J. Kraegen, E.W. 2003. The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 178, 373 383.
45. Hegarty, B.D., Foretz, M., Polkinghorne, E.C., Beale, S.M., Kraegen, E., Xu, A., Viollet, B., Carling, D. Cooney, G.J. 2008. Hepatic glucose production is inhibited acutely by high-molecular weight adiponectin via an AMPK-independent mechanism. FASEB Summer Research Conference August 2008 "AMPK in Sickness and Health: From Molecule to Man", Snekkersten, Denmark. (Abstract)
46. Herzig, S., Long, F., Jhala, U.S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., Spiegelman, B. Montminy, M. 2001. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413, 179 183.
47. Hirota, K., Sakamaki, J.I., Ishida, J., Shimamoto, Y., Nishihara, S., Kodama, N., Ohta, K., Yamamoto, M., Tanimoto, K. Fukamizu, A. 2008. A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding. J Biol Chem 283, 32432 32441.
48. Hojlund, K. 2003. AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes. Am J Physiol Endocrinol Metab 286, 239E 244E.
49. Holland, W.L., Knotts, T.A., Chavez, J.A., Wang, L.P., Hoehn, K.L. Summers, S.A. 2007. Lipid mediators of insulin resistance. Nutr Rev 65, S39 S46.
50. Holmes, B. 2005. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. AJP: Endocrinology and Metabolism 289, E1071 E1076.
51. Holmes, B.F., Kurth-Kraczek, E.J. Winder, W.W. 1999. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 87, 1990 1995.
52. Horike, N., Sakoda, H., Kushiyama, A., Ono, H., Fujishiro, M., Kamata, H., Nishiyama, K., Uchijima, Y., Kurihara, Y., Kurihara, H. Asano, T. 2009. AMPK activation increases phosphorylation of GSK3beta and thereby reduces CRE transcriptional activity and PEPCK-C gene expression in the liver. J Biol Chem 283, 33902 33910.
53. Horikoshi, M., Hara, K., Ohashi, J., Miyake, K., Tokunaga, K., Ito, C., Kasuga, M., Nagai, R. Kadowaki, T. 2006. A polymorphism in the AMPKalpha2 subunit gene is associated with insulin resistance and type 2 diabetes in the Japanese population. Diabetes 55, 919 923.
54. Hou, X., Xu, S., Maitland-Toolan, K., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T. Cohen, R. 2008. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283, 20015 20026.
55. Howitz, K.T., Bitterman, K.J., Cohen, H.Y., Lamming, D.W., Lavu, S., Wood, J.G., Zipkin, R.E., Chung, P., Kisielewski, A., Zhang, L.L., Scherer, B. Sinclair, D.A. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191 196.
56. Hundal, R.S., Krssak, M., Dufour, S., Laurent, D., Lebon, V., Chandramouli, V., Inzucchi, S.E., Schumann, W.C., Petersen, K.F., Landau, B.R. Shulman, G.I. 2000. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49, 2063 2069.
57. Iglesias, M.A., Ye, J.M., Frangioudakis, G., Saha, A.K., Tomas, E., Ruderman, N.B., Cooney, G.J. Kraegen, E.W. 2002. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 51, 2886 2894.
58. International Diabetes Federation. 2006. Diabetes Atlas 3rd Edn.
59. Itani, S.I., Ruderman, N.B., Schmieder, F. Boden, G. 2002. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51, 2005 2011.
60. Jäger, S., Handschin, C., St-Pierre, J. Spiegelman, B.M. 2007. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA 104, 12017 12022.
61. Jing, M., Cheruvu, V.K. Ismail-Beigi, F. 2008. Stimulation of glucose transport in response to activation of distinct AMPK signaling pathways. Am J Physiol Cell Physiol 295, C1071 C1082.
62. Jorgensen, S.B. Rose, A.J. 2008. How is AMPK activity regulated in skeletal muscles during exercise? Front Biosci 13, 5589 5604.
63. Jørgensen, S.B., Nielsen, J.N., Birk, J.B., Olsen, G.S., Viollet, B., Andreelli, F., Schjerling, P., Vaulont, S., Hardie, D., Hansen, B.F., Richter, E.A. Wojtaszewski, J.F. 2004a. The alpha2-5′AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. Diabetes 53, 3074 3081.
64. Jørgensen, S.B., Viollet, B., Andreelli, F., Frøsig, C., Birk, J.B., Schjerling, P., Vaulont, S., Richter, E.A. Wojtaszewski, J.F. 2004b. Knockout of the alpha2 but not alpha1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279, 1070 1079.
65. Ju, J.S., Gitcho, M.A., Casmaer, C.A., Patil, P.B., Han, D.G., Spencer, S.A. Fisher, J.S. 2007. Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase. Am J Physiol Cell Physiol 292, C564 C572.
66. Karnieli, E. Armoni, M. 2008. Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology. Am J Physiol Endocrinol Metab 295, E38 E45.
67. Kawaguchi, T., Osatomi, K., Yamashita, H., Kabashima, T. Uyeda, K. 2002. Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J Biol Chem 277, 3829 3835.
68. Kiens, B. 2006. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 86, 205 243.
69. Kim, S.P., Ellmerer, M., Van Citters, G.W. Bergman, R.N. 2003. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes 52, 2453 2460.
70. Kim, J.Y., Van De Wall, E., Laplante, M., Azzara, A., Trujillo, M., Hofmann, S., Schraw, T., Durand, J., Li, H., Li, G. et al. 2007. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117, 2621 2637.
71. Kim, J.A., Wei, Y. Sowers, J.R. 2008a. Role of mitochondrial dysfunction in insulin resistance. Circ Res 102, 401 414.
72. Kim, Y.D., Park, K.G., Lee, Y.S., Park, Y.Y., Kim, D.K., Nedumaran, B., Jang, W.G., Cho, W.J., Ha, J., Lee, I.K., Lee, C.H. Choi, H.S. 2008b. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57, 306 314.
73. Koistinen, H.A., Galuska, D., Chibalin, A.V., Yang, J., Zierath, J.R., Holman, G.D. Wallberg-Henriksson, H. 2003. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52, 1066 1072.
74. Kola, B., Boscaro, M., Rutter, G., Grossman, A. Korbonits, M. 2006. Expanding role of AMPK in endocrinology. Trends Endocrinol Metab 17, 205 215.
75. Koo, S., Flechner, L., Qi, L., Zhang, X., Screaton, R., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., Takemori, H. Montminy, M. 2005. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109 1111.
76. Kraegen, E.W. Cooney, G.J. 2008. Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol 19, 235 241.
77. Kraegen, E.W., Saha, A.K., Preston, E., Wilks, D., Hoy, A.J., Cooney, G.J. Ruderman, N.B. 2006. Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats. Am J Physiol Endocrinol Metab 290, E471 E479.
78. Kurth-Kraczek, E.J., Hirshman, M.F., Goodyear, L.J. Winder, W.W. 1999. 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48, 1667 1671.
79. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P. Auwerx, J. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109 1122.
80. LeBrasseur, N.K., Kelly, M., Tsao, T.S., Farmer, S.R., Saha, A.K., Ruderman, N.B. Tomas, E. 2006. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am J Physiol Endocrinol Metab 291, E175 E181.
81. Leclerc, I., Kahn, A. Doiron, B. 1998. The 5′-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex. FEBS Lett 431, 180 184.
82. Leclerc, I., Lenzner, C., Gourdon, L., Vaulont, S., Kahn, A. Viollet, B. 2001. Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 50, 1515 1521.
83. Lee, Y.S., Kim, W.S., Kim, K.H., Yoon, M.J., Cho, H.J., Shen, Y., Ye, J.M., Lee, C.H., Oh, W.K., Kim, C.T., Hohnen-Behrens, C., Gosby, A., Kraegen, E.W., James, D.E. Kim, J.B. 2006. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55, 2256 2264.
84. Liu, L., Zhang, Y., Chen, N., Shi, X., Tsang, B. Yu, Y. 2007. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest 117, 1679 1689.
85. Lochhead, P.A., Salt, I.P., Walker, K.S., Hardie, D.G. Sutherland, C. 2000. 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49, 896 903.
86. Long, Y.C. Zierath, J.R. 2006. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116, 1776 1783.
87. Mayr, B. Montminy, M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2, 599 609.
88. McGarry, J.D. 1992. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258, 766 770.
89. McGee, S.L. Hargreaves, M. 2004. Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes 53, 1208 1214.
90. McGee, S., Van Denderen, B., Howlett, K., Mollica, J., Schertzer, J., Kemp, B. Hargreaves, M. 2007. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57, 860 867.
91. Merrill, G.F., Kurth, E.J., Hardie, D.G. Winder, W.W. 1997. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273, E1107 E1112.
92. Minokoshi, Y., Kim, Y.B., Peroni, O.D., Fryer, L.G., Müller, C., Carling, D. Kahn, B.B. 2002. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339 343.
93. Minokoshi, Y., Alquier, T., Furukawa, N., Kim, Y.B., Lee, A., Xue, B., Mu, J., Foufelle, F., Ferré, P., Birnbaum, M.J., Stuck, B. Kahn, B.B. 2004. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569 574.
94. Minokoshi, Y., Shiuchi, T., Lee, S., Suzuki, A. Okamoto, S. 2008. Role of hypothalamic AMP-kinase in food intake regulation. Nutrition 24, 786 790.
95. Miyamoto, L., Toyoda, T., Hayashi, T., Yonemitsu, S., Nakano, M., Tanaka, S., Ebihara, K., Masuzaki, H., Hosoda, K., Ogawa, Y., Inoue, G., Fushiki, T. Nakao, K. 2007. Effect of acute activation of 5′-AMP-activated protein kinase on glycogen regulation in isolated rat skeletal muscle. J Appl Physiol 102, 1007 1013.
96. Mu, J., Brozinick, J.T., Valladares, O., Bucan, M. Birnbaum, M. 2001. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7, 1085 1094.
97. Muoio, D.M., Seefeld, K., Witters, L.A. Coleman, R.A. 1999. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338 (Pt 3 783 791.
98. Muse, E.D., Obici, S., Bhanot, S., Monia, B.P., McKay, R.A., Rajala, M.W., Scherer, P.E. Rossetti, L. 2004. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 114, 232 239.
99. Musi, N., Fujii, N., Hirshman, M.F., Ekberg, I., Fröberg, S., Ljungqvist, O., Thorell, A. Goodyear, L.J. 2001. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 50, 921 927.
100. Musi, N., Hirshman, M.F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J.M., Ljunqvist, O., Efendic, S., Moller, D.E., Thorell, A. Goodyear, L.J. 2002. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51, 2074 2081.
101. Nakae, J., Oki, M. Cao, Y. 2008. The FoxO transcription factors and metabolic regulation. FEBS Lett 582, 54 67.
102. Narkar, V.A., Downes, M., Yu, R.T., Embler, E., Wang, Y.X., Banayo, E., Mihaylova, M.M., Nelson, M.C., Zou, Y., Juguilon, H., Kang, H., Shaw, R.J. Evans, R.M. 2008. AMPK and PPARdelta agonists are exercise mimetics. Cell 134, 405 415.
103. Nawrocki, A.R., Rajala, M.W., Tomas, E., Pajvani, U.B., Saha, A.K., Trumbauer, M.E., Pang, Z., Chen, A.S., Ruderman, N.B., Chen, H., Rossetti, L. Scherer, P.E. 2006. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281, 2654 2660.
104. Owen, M.R., Doran, E. Halestrap, A.P. 2000. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348 (Pt 3 607 614.
105. Palanivel, R. Sweeney, G. 2005. Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin. FEBS Lett 579, 5049 5054.
106. Pang, T., Zhang, Z.S., Gu, M., Qiu, B.Y., Yu, L.F., Cao, P.R., Shao, W., Su, M.B., Li, J.Y., Nan, F.J. Li, J. 2008. Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells. J Biol Chem 283, 16051 16060.
107. Park, H. 2002. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J Biol Chem 277, 32571 32577.
108. Postic, C., Dentin, R. Girard, J. 2004. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 30, 398 408.
109. Puljak, L., Parameswara, V., Dolovcak, S., Waldrop, S.L., Emmett, D., Esser, V., Fitz, J.G. Kilic, G. 2008. Evidence for AMPK-dependent regulation of exocytosis of lipoproteins in a model liver cell line. Exp Cell Res 314, 2100 2109.
110. Ruderman, N.B. Saha, A.K. 2006. Metabolic syndrome: adenosine monophosphate-activated protein kinase and malonyl coenzyme A. Obesity (Silver Spring) 14 (Suppl. 1 25S 33S.
111. Saha, A.K., Schwarsin, A.J., Roduit, R., Masse, F., Kaushik, V., Tornheim, K., Prentki, M. Ruderman, N.B. 2000. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside. J Biol Chem 275, 24279 24283.
112. Saha, A.K., Avilucea, P.R., Ye, J.M., Assifi, M.M., Kraegen, E.W. Ruderman, N.B. 2004. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem Biophys Res Commun 314, 580 585.
113. Sakamoto, K. Holman, G.D. 2008. Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am J Physiol Endocrinol Metab 295, E29 E37.
114. Sakamoto, K., Mccarthy, A., Smith, D., Green, K.A., Grahame Hardie, D., Ashworth, A. Alessi, D. 2005. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 24, 1810 1820.
115. Sanders, M.J., Grondin, P.O., Hegarty, B.D., Snowden, M.A. Carling, D. 2007. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J 403, 139 148.
116. Sano, H., Kane, S., Sano, E., Mîinea, C.P., Asara, J.M., Lane, W.S., Garner, C.W. Lienhard, G.E. 2003. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 278, 14599 14602.
117. Savage, D.B., Petersen, K.F. Shulman, G.I. 2007. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87, 507 520.
118. Schraw, T., Wang, Z.V., Halberg, N., Hawkins, M. Scherer, P.E. 2008. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 149, 2270 2282.
119. Shaw, R.J., Lamia, K.A., Vasquez, D., Koo, S., Bardeesy, N., Depinho, R.A., Montminy, M. Cantley, L.C. 2005. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642 1646.
120. Shklyaev, S., Aslanidi, G., Tennant, M., Prima, V., Kohlbrenner, E., Kroutov, V., Campbell-Thompson, M., Crawford, J., Shek, E.W., Scarpace, P.J. Zolotukhin, S. 2003. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci USA 100, 14217 14222.
121. Simha, V. Garg, A. 2006. Lipodystrophy: lessons in lipid and energy metabolism. Curr Opin Lipidol 17, 162 169.
122. Sriwijitkamol, A., Coletta, D.K., Wajcberg, E., Balbontin, G.B., Reyna, S.M., Barrientes, J., Eagan, P.A., Jenkinson, C.P., Cersosimo, E., DeFronzo, R.A., Sakamoto, K. Musi, N. 2007. Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study. Diabetes 56, 836 848.
123. 2+/calmodulin-dependent protein kinase kinase beta. Mol Cell Biol 26, 5933 5945.
124. Steinberg, G.R., Parolin, M.L., Heigenhauser, G.J. Dyck, D.J. 2002. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283, E187 E192.
125. Steinberg, G.R., Smith, A.C., Van Denderen, B.J., Chen, Z., Murthy, S., Campbell, D.J., Heigenhauser, G.J., Dyck, D.J. Kemp, B.E. 2004. AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J Clin Endocrinol Metab 89, 4575 4580.
126. Steinberg, G.R., McAinch, A.J., Chen, M.B., O'Brien, P.E., Dixon, J.B., Cameron-Smith, D. Kemp, B.E. 2006a. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab 91, 3592 3597.
127. Steinberg, G.R., Michell, B.J., van Denderen, B.J., Watt, M.J., Carey, A.L., Fam, B.C., Andrikopoulos, S., Proietto, J., Görgün, C.Z., Carling, D., Hotamisligil, G.S., Febbraio, M., Kay, T.W. Kemp, B.E. 2006b. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metabolism 4, 465 474.
128. Storlien, L.H., Jenkins, A.B., Chisholm, D.J., Pascoe, W.S., Khouri, S. Kraegen, E.W. 1991. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40, 280 289.
129. Suter, M., Riek, U., Tuerk, R., Schlattner, U., Wallimann, T. Neumann, D. 2006. Dissecting the role of 5′-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J Biol Chem 281, 32207 32216.
130. Swarbrick, M.M. Havel, P.J. 2008. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 6, 87 102.
131. 2+ in T lymphocytes. J Exp Med 203, 1665 1670.
132. Tan, M.J., Ye, J.M., Turner, N., Hohnen-Behrens, C., Ke, C.Q., Tang, C.P., Chen, T., Weiss, H.C., Gesing, E.R., Rowland, A., James, D.E. Ye, Y. 2008. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol 15, 263 273.
133. Tanaka, T., Hidaka, S., Masuzaki, H., Yasue, S., Minokoshi, Y., Ebihara, K., Chusho, H., Ogawa, Y., Toyoda, T., Sato, K. et al. 2005. Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification. Diabetes 54, 2365 2374.
134. Timmers, S., Schrauwen, P. de Vogel, J. 2008. Muscular diacylglycerol metabolism and insulin resistance. Physiol Behav 94, 242 251.
135. Treebak, J., Birk, J., Rose, A., Kiens, B., Richter, E. Wojtaszewski, J. 2006. AS160 phosphorylation is associated with activation of 2beta2 1- but not 2beta2 3-AMPK trimeric complex in skeletal muscle during exercise in humans. AJP: Endocrinology and Metabolism 292, E715 E722.
136. Turner, N. Heilbronn, L. 2008. Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol Metab 19, 324 330.
137. Turner, N., Bruce, C.R., Beale, S.M., Hoehn, K.L., So, T., Rolph, M.S. Cooney, G.J. 2007. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56, 2085 2092.
138. Turner, N., Gosby, A., To, S.W., Cheng, Z., Miyoshi, H., Taketo, M.M., Cooney, G.J., Kraegen, E.W., James, D.E., Hu, L.H., Li, J. Ye, J.M. 2008. Berberine, and its more biologically available derivative dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMPK and improve insulin action. Diabetes 57, 1414 1418.
139. Vaillancourt, V.A., Larsen, S.D., Tanis, S.P., Burr, J.E., Connell, M.A., Cudahy, M.M., Evans, B.R., Fisher, P.V., May, P.D., Meglasson, M.D., Robinson, D.D., Stevens, F.C., Tucker, J.A., Vidmar, T.J. Yu, J.H. 2001. Synthesis and biological activity of aminoguanidine and diaminoguanidine analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid. J Med Chem 44, 1231 1248.
140. Velasco, G., Geelen, M.J. Guzmán, M. 1997. Control of hepatic fatty acid oxidation by 5′-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch Biochem Biophys 337, 169 175.
141. Viollet, B., Andreelli, F., Jørgensen, S.B., Perrin, C., Flamez, D., Mu, J., Wojtaszewski, J.F., Schuit, F.C., Birnbaum, M., Richter, E., Burcelin, R. Vaulont, S. 2003a. Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem Soc Trans 31, 216 219.
142. Viollet, B., Andreelli, F., Jørgensen, S.B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M. et al. 2003b. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111, 91 98.
143. Watt, M.J. Steinberg, G.R. 2008. Regulation and function of triacylglycerol lipases in cellular metabolism. Biochem J 414, 313 325.
144. Winder, W.W. Hardie, D.G. 1999. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277, E1 E10.
145. Winder, W.W., Holmes, B.F., Rubink, D.S., Jensen, E.B., Chen, M. Holloszy, J.O. 2000. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88, 2219 2226.
146. Wojtaszewski, J.F., Nielsen, P., Hansen, B.F., Richter, E.A. Kiens, B. 2000. Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J Physiol (Lond) 528 (Pt 1 221 226.
147. Woods, A., Azzout-Marniche, D., Foretz, M., Stein, S.C., Lemarchand, P., Ferré, P., Foufelle, F. Carling, D. 2000. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20, 6704 6711.
148. Xiao, B., Heath, R., Saiu, P., Leiper, F., Leone, P., Jing, C., Walker, P., Haire, L., Eccleston, J., Davis, C., Martin, S., Carling, D. Gamblin, S. 2007. Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 449, 496 500.
149. Xue, B. Kahn, B.B. 2006. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J Physiol (Lond) 574, 73 83.
150. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K. et al. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288 1295.
151. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M. et al. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762 769.
152. Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T. et al. 2007. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13, 332 339.
153. Yano, W., Kubota, N., Itoh, S., Kubota, T., Awazawa, M., Moroi, M., Sugi, K., Takamoto, I., Ogata, H., Tokuyama, K., Noda, T., Terauchi, Y., Ueki, K. Kadowaki, T. 2008. Molecular mechanism of moderate insulin resistance in adiponectin-knockout mice. Endocr J 55, 515 522.
154. Ye, J.M., Frangioudakis, G., Iglesias, M.A., Furler, S.M., Ellis, B., Dzamko, N., Cooney, G.J. Kraegen, E.W. 2002. Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver. Endocrinology 143, 4527 4535.
155. Yin, J., Gao, Z., Liu, D., Liu, Z. Ye, J. 2008. Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab 294, E148 E156.
156. Yoon, J.C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C.R., Granner, D.K., Newgard, C.B. Spiegelman, B.M. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131 138.
157. Yu, X., Mccorkle, S., Wang, M., Lee, Y., Li, J., Saha, A.K., Unger, R.H. Ruderman, N.B. 2004. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia 47, 2012 2021.
158. Zang, M., Zuccollo, A., Hou, X., Nagata, D., Walsh, K., Herscovitz, H., Brecher, P., Ruderman, N.B. Cohen, R.A. 2004. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 279, 47898 47905.
159. Zang, M., Xu, S., Maitland-Toolan, K.A., Zuccollo, A., Hou, X., Jiang, B., Wierzbicki, M., Verbeuren, T.J. Cohen, R.A. 2006. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55, 2180 2191.
160. Zhang, L., He, H. Balschi, J.A. 2007. Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration. Am J Physiol Heart Circ Physiol 293, H457 H466.
161. Zhao, G., Iyengar, R.R., Judd, A.S., Cool, B., Chiou, W., Kifle, L., Frevert, E., Sham, H. Kym, P.R. 2007. Discovery and SAR development of thienopyridones: a class of small molecule AMPK activators. Bioorg Med Chem Lett 17, 3254 3257.
162. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M.F., Goodyear, L.J. Moller, D.E. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108, 1167 1174.
163. Zong, H., Ren, J.M., Young, L.H., Pypaert, M., Mu, J., Birnbaum, M.J. Shulman, G.I. 2002. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci USA 99, 15983 15987.